mRNA |
BAY 61-3606 |
GDSC1000 |
pan-cancer |
AAC |
0.036 |
0.3 |
mRNA |
Bexarotene |
GDSC1000 |
pan-cancer |
AAC |
0.038 |
0.3 |
mRNA |
erastin |
CTRPv2 |
pan-cancer |
AAC |
-0.037 |
0.3 |
mRNA |
BRD-K96970199 |
CTRPv2 |
pan-cancer |
AAC |
-0.075 |
0.3 |
mRNA |
selumetinib:GDC-0941 (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.037 |
0.3 |
mRNA |
LY317615 |
GDSC1000 |
pan-cancer |
AAC |
-0.036 |
0.3 |
mRNA |
BRD-K27986637 |
CTRPv2 |
pan-cancer |
AAC |
-0.075 |
0.3 |
mRNA |
AS601245 |
GDSC1000 |
pan-cancer |
AAC |
0.036 |
0.3 |
mRNA |
doxorubicin:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.034 |
0.3 |
mRNA |
Compound 23 citrate |
CTRPv2 |
pan-cancer |
AAC |
0.035 |
0.3 |